Meeting

Roundtable on Health Literacy Meeting 5


When: October 12, 2007 (10:21 AM Eastern)
Where: Keck Center • 500 Fifth St. NW, Washington, DC 20001

Topics Public Health, Quality and Patient Safety, Select Populations and Health Equity
Activity: Roundtable on Health Literacy
Board: Board on Population Health and Public Health Practice

The Roundtable on Health Literacy held its fifth workshop on Friday, October 12th in Room 100 of the Keck Center of the National Academies, located at 500 5th Street, NW, Washington, DC. The workshop focused on "Improving Prescription Drug Use Container Instructions: An Issue of Health Literacy and Medication Safety," and was open to the public. 

Agenda
Changing Prescription Medication Use Container Instructions
to Improve Health Literacy and Medication Safety
October 12, 2007
8:30 a.m. -5:30 p.m.
Room 100
Keck Center of the National Academies
500 5th Street, NW
Washington, DC 2001

8:30-8:40: Welcome and Opening Remarks

8:40-9:00: Drug Safety in Ambulatory Care--Where is the Patient?
Dan Budnitz, MD
Medical Officer
Division of Healthcare Quality Promotion,
Coordinating Center for Infectious Diseases, CDC

9:00-9:15: To Err is Human: The Role of Health Literacy in Patient Care
Terry C. Davis, Ph.D.
Professor of Medicine and Pediatrics
Louisiana State University Health Sciences Center

9:15-9:45: Findings of the ACP Foundation White Paper on Drug Labeling
Michael Wolf, Ph.D., M.P.H.
Feinberg School of Medicine, Northwestern University

9:45-10:00: Discussion of Morning Presentations

10:00-10:30: Simplification of Drug Dosing Times: Can We Confuse Patients Less? A Proposal for Standardization
Alastair J.J. Wood, M.D., F.A.C.P.
Managing Director
Symphony Capital LLC

10:30-11:30: Panel I, Federal Agency Reaction  to Prescription Use Instruction Standardization

Carolyn M. Clancy, M.D.
Director, Agency for Healthcare Research and Quality

Nancy Ostrove, Ph.D
Senior Advisor for Risk Communication, Office of Planning, Office of the Commissioner, Food and Drug Administration

Virginia Torrise, Pharm.D.
Deputy Chief Consultant for Pharmacy Benefits Management
Department of Veterans Affairs

CMS- TBD

11:30-12:45: Panel II, Pharmacy Reaction to Prescription Use Instruction Standardization

Alan Goldhammer, PhD
Deputy Vice President, Regulatory Affairs
PhRMA

Darren K. Townzen RPh MBA
Director of Pharmacy Systems – Wal-Mart
Susan Guckian
National Association of Chain Drug Stores

TBD Representative from
Pharmaceutical Care Management Association

Gerald McEvoy, Pharm.D.
Assistant Vice President on Drug Information
American Society of Health-System Pharmacists

William Ellis, RPh., MS
Chief Executive Officer
American Pharmacists Association Foundation


12:45-1:30: Lunch Break

1:30-2:40 Panel IIIa, Other Stakeholder Reaction to Prescription Use Instruction Standardization: Physicians and Patients

William Dolan, MD
AMA Board Member
American Medical Association

Albert Wu, M.D., M.P.H.
Bloomberg School of Public Health, Johns Hopkins University

William Bullman
Executive Vice President
National Council on Patient Information and Education

Linda Weiss, Ph.D.
Center for Urban Epidemiologic Studies
New York Academy of Medicine

Mara Youdelman, J.D.
Staff Attorney
National Health Law Program

2:40-3:10: Panel IIIa, Other Stakeholder Reaction to Prescription Use Instruction Standardization: Educators of Pharmacists and Physicians

Mary Ann F. Kirkpatrick, PhD : Teaching Future Pharmacists about Prescription Medication Use Container Instructions to Improve Health Literacy & Medication Safety
Associate Dean for Student Affairs
Shenandoah University Bernard J. Dunn School of Pharmacy
American Association of Colleges of Pharmacy

Dr. Merrill Egorin, MD
Professor of Medicine and Pharmacology
University of Pittsburgh School of Medicine
Co-Director, Molecular Therapeutics/Drug Discovery Program
University of Pittsburgh Cancer Institute
AAMC, Expert Panel on Education in Safe and Effective Prescribing Practices

3:10-3:25: Break

3:30-4:45: Panel IV, What Would It Take to Move Towards Prescription Use Instruction Standardization?

Roger Williams, M.D.
Executive Vice President
Chief Executive Officer
United States Pharmacopeia

Darren K. Townzen RPh MBA
Director of Pharmacy Systems – Wal-Mart
National Council for Prescription Drug Programs, Inc

Susan Johnson, Ph.D
Associate Director of the Office of Nonprescription Products
Food and Drug Administration

Ms. Vanessa Cajina,
Latino Coalition for a Healthy California


4:45-5:30: Summary and  Discussion

 

Previous Meetings for this Activity

Also of Interest